A case of Beh‡et's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

被引：94
|
作者：
Hirano, Toru [1 ]
Ohguro, Nobuyuki [2 ]
Hohki, Satoshi [3 ]
Hagihara, Keisuke [1 ]
Shima, Yoshihito [1 ]
Narazaki, Masashi [1 ]
Ogata, Atsushi [1 ]
Yoshizaki, Kazuyuki [4 ]
Kumanogoh, Atsushi [1 ]
Kishimoto, Tadamitsu [5 ]
Tanaka, Toshio [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan
[2] Osaka Koseinenkin Hosp, Dept Ophthalmol, Osaka, Japan
[3] Toyama Univ, Dept Ophthalmol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan
[4] Osaka Univ, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan
[5] Osaka Univ, Lab Immune Regulat, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan
来源：
MODERN RHEUMATOLOGY | 2012年 / 22卷 / 02期
关键词：
Behcet's disease; IL-6; Tocilizumab; GENOME-WIDE ASSOCIATION; BEHCETS-DISEASE; CEREBROSPINAL-FLUID; INTERLEUKIN-6; IL23R-IL12RB2; GENERATION; THERAPY; CELLS; IL10;
D O I：
10.1007/s10165-011-0497-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 47-year-old female patient with Beh double dagger et's disease had been treated with colchicine, prednisolone, cyclosporine A, and infliximab. Because she relapsed, however, treatment with tocilizumab, a humanized anti-interleukin 6 receptor antibody, was started. This treatment suppressed the patient's clinical manifestations, including ocular attacks, for 1 year and improved her visual acuity. This experience indicates that tocilizumab may constitute a therapeutic option for refractory Beh double dagger et's disease.
引用
收藏
页码：298 / 302
页数：5
相关论文
共 50 条
  • [21] Therapeutic efficacy of humanized anti-interleukin-6 receptor monoclonal antibody in renal involvement complicating Castleman's disease
    Kanai, Hidetoshi
    Hirano, Tadashi
    Arimura, Yosihide
    Yokota, Tadaaki
    Masutani, Kosuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 290 - 290
  • [22] Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
    Tanaka, Toshio
    Ogata, Atsushi
    Shima, Yoshihito
    Narazaki, Masashi
    Kumanogoh, Atsushi
    Kishimoto, Tadamitsu
    CURRENT RHEUMATOLOGY REVIEWS, 2012, 8 (03) : 209 - 226
  • [23] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis
    Uchiyama, Yasushi
    Yorozu, Keigo
    Hashizume, Misato
    Moriya, Yoichiro
    Mihara, Masahiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (06) : 1159 - 1163
  • [24] Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
    Okuda, Yasuaki
    Takasugi, Kiyoshi
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2997 - 3000
  • [25] Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia
    Ando, Katsutoshi
    Takahashi, Fumiyuki
    Motojima, Shinji
    Nakashima, Kei
    Kaneko, Norihiro
    Hoshi, Kazuei
    Takahashi, Kazuhisa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : E69 - E72
  • [26] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
    Hashizume, Misato
    Uchiyama, Yasushi
    Horai, Naoto
    Tomosugi, Naohisa
    Mihara, Masahiko
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (07) : 917 - 923
  • [27] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
    Misato Hashizume
    Yasushi Uchiyama
    Naoto Horai
    Naohisa Tomosugi
    Masahiko Mihara
    Rheumatology International, 2010, 30 : 917 - 923
  • [28] Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
    Sugimoto, K
    Nishimoto, N
    Kishimoto, T
    Yoshizaki, K
    Nishimura, T
    ANNALS OF NUCLEAR MEDICINE, 2005, 19 (04) : 261 - 266
  • [29] Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody
    Nishimoto, Norihiro
    Nakahara, Hideko
    Yoshio-Hoshino, Naoko
    Mima, Toru
    ARTHRITIS AND RHEUMATISM, 2008, 58 (04): : 1197 - 1200
  • [30] Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
    Kanji Sugimoto
    Norihiro Nishimoto
    Tadamitsu Kishimoto
    Kazuyuki Yoshizaki
    Tsunehiko Nishimura
    Annals of Nuclear Medicine, 2005, 19 : 261 - 266
12345